Antioxidants and Platelets

References

• Gey K. F. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 1986; 37: 53–91
   PubMedGoogle Scholar
• Burton G. W., Cheeseman K. H., Doba T., Ingold K. U., Slater T. F. Biology of vitamin E, Ciba Foundation symposium No. 101. R. Porter, J. Wheelan. Elsevier, Amsterdam 1983; 4–14
   Google Scholar
• Salonen J. T. Selenium in ischaemic heart disease. Int J Epidemiol 1987; 16: 323–8
   PubMed Web of Science ®Google Scholar
• Salonen J. T. Selenium in cardiovascular diseases and cancer. Epidemiologic findings from Finland. Scandia International Symposia. Trace elements in health and disease. Stockholm. Almqvist & Wicksell International. 1985; 172–86
   Google Scholar
• Ham E. A., Egan R. W., Soderman D. D., Gale P. H., Kuehl F. A., Jr. Peroxidasedependent deactivation of prostacyclin synthetase. J Biol Chem 1979; 254: 2191
   PubMed Web of Science ®Google Scholar
• Turk J., Wyche A., Needleman P. Inactivation of vascular prostacyclin synthetase by platelet lipoxygenase products. Biochem Biophys Res Commun 1980; 95: 1628
   PubMed Web of Science ®Google Scholar
• Sussman I. I. The Role of Platelets in Atherogenesis/Atherosclerosis. The Platelets: Physiology and Pharmacology, G. L. Longenecker. Academic Press Inc., London 1985; 383–405
   Google Scholar
• Szczeklik A., Gryglewski R. J. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PG12) biosynthesis in arteries. Artery 1980; 7: 488–95
   PubMedGoogle Scholar
• Szczeklik A., Gryglewski R. J., Domagala B., Zmuda A., Harwich J., Wozny E., Grzywacz M., Madej J., Gryglewska T. Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patient with coronary heart disease. Prostaglandins 1981; 22: 795–807
   PubMedGoogle Scholar
• Nishida T., Kummerow F. A. Interaction of serum lipoproteins with the hydroperoxide of methyl linoleate. J Lipid Res 1960; 1: 450–8
   PubMedGoogle Scholar
• Morel D. W., Hessler J. R., Chisolm G. M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983; 24: 1070–76
   PubMed Web of Science ®Google Scholar
• Van Hinsbergh V. W. M. LDL cytotoxicity. The state of the art. Atherosclerosis 1984; 53: 113–8
   PubMed Web of Science ®Google Scholar
• Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883–87
   PubMed Web of Science ®Google Scholar
• Machlln L. J., Fmipski R., Willis A. L., et al. Influence of vitamin E on platelet aggregation and thrombocytemia in the rat. Proc Soc Exp Biol Med 1975; 149: 275
   Google Scholar
• Stuart M. J., Oski F. A. Vitamin E and platelet function. Am J Pediatr Hematol Oncol 1979; 1: 77s–82s
   Google Scholar
• Steiner M. Effect of alpha-tocopherol administration on platelet function in man. Thromb Haemost 1983; 49: 73–7
   PubMed Web of Science ®Google Scholar
• Srivastava K. C. Vitamin E exerts antiaggregatory effects without inhibiting the enzymes of the arachidonic acid cascade in platelets. Prostaglandins Leukotrienes Med 1986; 21: 177–85
   PubMedGoogle Scholar
• Szczeklik A., Gryglewski R. J., Domagala B., Dworski R., Basista M. Dietary supplementation with vitamin E in hyperlipoproteinemias: Effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost 1985; 54: 425–30
   PubMed Web of Science ®Google Scholar
• Colette C., Monnier L. H., Cartry E. Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E. Am J Clin Nutr 1988; 47: 256–61
   Google Scholar
• Giani E., Masl I., Galll C. Heated fat, vitamin E and vascular eicosanoids. Lipids 1985; 20: 439–48
   Google Scholar
• Swartz S. L., Willet W. C., Hennekens C. H. A randomized trial of the effect of vitamin E on plasma prostacyclin (6-keto-PGF, J levels in healthy adults. Prostaglandins Leukotrienes Med 1985; 18: 105–11
   PubMedGoogle Scholar
• Stampfer M. J., Jakubowski J. A., Faigel D., Vaillancourt R., Deykin D. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels. Am J Clin Nutr 1988; 47: 700–6
   PubMed Web of Science ®Google Scholar
• Bordia A., Verma S. K. Effect of vitamin C on platelet adhesiveness and platelet aggregation in coronary artery disease patients. Clin Cardiol 1985; 8: 552–4
   PubMed Web of Science ®Google Scholar
• Gordova C., Musca A., Violi F., Perrone A., Alessandri C. Influence of ascorbic acid on platelet aggregation in vitro and in vivo. Atherosclerosis 1982; 41: 15–9
   Google Scholar
• Srivastava K. C. Ascorbic acid enhances the formation of prostaglandin E, in washed human platelets and prostacyclin in rat aortic rings. Prostaglandins Leukotrienes Med 1985; 18: 227–33
   Google Scholar
• Beetens J. R., Herman A. G. Vitamin C increases the formation of prostacyclin by aortic rings from various species and neutralizes the inhibitory effect of 15-hydroperoxy-arachidonic acid. Br J Pharmacol 1983; 80: 249
   PubMed Web of Science ®Google Scholar
• Meade T. W., North W. R. S. Population-based distributions of haemostatic variables. Br Med Bull 1977; 33: 283–8
   PubMed Web of Science ®Google Scholar
• Meade T. W., Vickers M. V., Thompson S. G., Stirling Y., Haines A. P., Miller G. J. Epidemiological characteristics of platelet aggregability. Br Med J 1985; 290: 428–32
   PubMed Web of Science ®Google Scholar
• Salonen J. T. Is there a continuing need for longitudinal epidemiologic research? – The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 1988; 20: 46–50
   PubMedGoogle Scholar
• Salonen J. T., Salonen R., Seppanen K., Kantola M., Parviai-nen M., Alfthan G., Maenpaa P. H., Taskinen E., Rauramaa R. Relationship of serum selenium and antioxidants to plasma lipoprotein, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988; 70: 155–60
   PubMed Web of Science ®Google Scholar
• Renaud S., Dumont E., Godsey F., et al. Platelet functions in relation to dietary fats in farmers from two regions of France. Thromb Haemost 1978; 40: 518–31
   Google Scholar
• Renaud S., Dumont E., Godsey F., McGregor L., Morazin R. Effects of diet on blood clotting and platelet aggregation. Nutrition in the 1980s: Constrains on our knowledge, S. Renaud, E. Dumont, F. Godsey, L. McGregor, R. Morazin. Liss, New York 1981; 361–81
   Google Scholar
• Salonen J. T., Lakka T. Assessment of physical activity in population studies - validity and consistency of the methods in the Kuopio ischemic heart disease risk factor study. Scand J Sports Sci 1987; 9: 89–95
   Google Scholar
• Penttila I., Huhtikangas A., Herranen J., Eskelinen S., Moila-nen O. Simultaneous measurement of free and esterified fatty acids by gas gromatography from normal and type IV hyperlipoproteinaemic sera. Ann Clin Res 1984; 16: 13–7
   Google Scholar